Open claims vs. closed payer claims: What’s the difference?
Open claims and closed payer claims data are essential for understanding the status and activities...
Menopause at a turning point: RWD matters more than ever
A recent CNBC article used HealthVerity real-world data (RWD) to highlight a shortage of estrogen patches that is visible in RWD as demand for menopause support skyrockets. Menopause affects millions of women, yet it has long remained one of the...
MASH disease: From silent epidemic to treatment options
Liver disease is a growing global health concern, yet many of its most serious forms remain...
Why reliable mortality measurement in real-world evidence matters
Understanding mortality in taXonomy and the importance of post mortem activity This is the third...
Why underpowered studies are more dangerous than you think
In epidemiology, statistical power determines whether a study can accurately detect an effect of a...
When billed and allowed amounts aren’t enough: HealthVerity market cost offering in taXonomy
A better way to measure healthcare costs in closed claims data This is the second post in our...
Does your data link?
How clinical data linkage closes evidence gaps in real-world data Clinical data linkage helps...
Why 'good enough' data is risky
Real World Data (RWD) is increasingly being incorporated into healthcare and life science research...
Can you trust AI for RWE? HealthVerity eXOs validation study says yes
Artificial intelligence is moving quickly into healthcare research, but one question still comes...
The role of real-world data in advancement of Alzheimer’s treatments
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Inside taXonomy, a next-gen closed claims solution for real-world evidence generation
Healthcare claims data are one of the most powerful sources of data in generating real-world...